Found: 6
Select item for more details and to access through your institution.
Effects of pitavastatin on walking capacity and CD34/133 cell number in patients with peripheral artery disease.
- Published in:
- Heart & Vessels, 2017, v. 32, n. 10, p. 1186, doi. 10.1007/s00380-017-0988-1
- By:
- Publication type:
- Article
Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy.
- Published in:
- European Heart Journal, 2019, v. 40, n. 22, p. 1778, doi. 10.1093/eurheartj/ehz119
- By:
- Publication type:
- Article
Febuxostat and renal outcomes: post-hoc analysis of a randomized trial.
- Published in:
- Hypertension Research, 2023, v. 46, n. 6, p. 1417, doi. 10.1038/s41440-023-01198-x
- By:
- Publication type:
- Article
Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomized controlled trial.
- Published in:
- Rheumatology, 2022, v. 61, n. 6, p. 2346, doi. 10.1093/rheumatology/keab739
- By:
- Publication type:
- Article
Impacts of Febuxostat on Cerebral and Cardiovascular Events in Elderly Patients with Hyperuricemia: Post Hoc Analysis of a Randomized Controlled Trial.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 6, p. 1358, doi. 10.1002/cpt.3217
- By:
- Publication type:
- Article
C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 965, doi. 10.1007/s10557-022-07347-7
- By:
- Publication type:
- Article